Bladder PREserVation by RadioTherapy and Immunotherapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer
NCT03950362
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
67
Enrollment
OTHER
Sponsor class
Conditions
Non-muscle-invasive Bladder Cancer
Interventions
DRUG:
Avelumab
DEVICE:
Radiotherapy
Sponsor
Institut Paoli-Calmettes